RT Book, Section A1 Kim-Katz, Susan A2 Olson, Kent R. A2 Anderson, Ilene B. A2 Benowitz, Neal L. A2 Blanc, Paul D. A2 Clark, Richard F. A2 Kearney, Thomas E. A2 Kim-Katz, Susan Y. A2 Wu, Alan H. B. SR Print(0) ID 1174605317 T1 BETA2-ADRENERGIC STIMULANTS T2 Poisoning & Drug Overdose, 7e YR 2018 FD 2018 PB McGraw-Hill Education PP New York, NY SN 9780071839792 LK accessmedicine.mhmedical.com/content.aspx?aid=1174605317 RD 2024/10/14 AB Beta-adrenergic agonists can be broadly categorized as having beta1 and beta2 receptor activity. This section describes the toxicity of beta2-selective agonists that are commonly available for oral use: albuterol (salbutamol), metaproterenol, and terbutaline (Table II–16). Clenbuterol, a potent beta2 agonist, is not approved for human use in the United States but is abused for its anabolic effects.